Journal Of Clinical Oncology (jco) Podcast
Minimal Residual Disease (MRD) in Acute Myeloid Leukemia- Are we Ready for Individualized Risk Assessment Based on MRD?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:21
- Mas informaciones
Informações:
Sinopsis
Before we can use MRD as a guide of post-remission therapy in AML, we have to standardize our methods for MRD quantification and agree on the definition of MRD-positive versus MRD-negative patients.
